Balance Sheet

Current Liabilities	29.4m
Accounts Payable	6.5m
Other Current Liabilities	22.9m
Non-Current Liabilities	3.6m
Long-Term Debt	713.1k
Other Non-Current Liabilities	2.9m

Currency: AUD

	Jun-2014	Jun-2015	Jun-2016	Jun-2017	Jun-2018	Jun-2019	Jun-2020	Jun-2021	Jun-2022	Jun-2023
Assets
Cash & Cash Equivalents	2	3	4	14	17	24	24	35	23	23
Cash	2	3	4	14	17	24	24	35	23	23
Short-Term Investments	13	8	10	10	20	30	43	48	99	134
Total Receivables	2	2	5	3	5	4	7	16	16	22
Accounts Receivables	2	2	5	3	5	4	7	16	16	22
Other Receivables	0	0	0	0	0	0	0	0	0	0
Inventory	0	1	1	1	1	2	1	3	2	10
Other Current Assets	1	0	0	0	0	1	1	1	1	1
Total Current Assets	17	14	20	28	42	61	75	103	141	190
PP&E Net	0	0	0	0	0	1	2	3	3	3
PP&E Gross	0	0	0	0	0	1	2	3	3	3
Accumulated Depreciation	0	0	0	0	0	0	1	1	2	2
Goodwill	0	0	0	0	0	0	0	0	0	0
Other Long-Term Assets	0	0	0	0	0	0	4	3	0	1
Other Assets	0	0	0	0	0	0	0	0	0	0
Total Assets	17 N/A	14 -20%	20 +48%	29 +42%	43 +50%	62 +45%	82 +31%	109 +33%	144 +33%	194 +35%
Liabilities
Accounts Payable	1	2	2	2	2	4	5	5	3	8
Accrued Liabilities	1	1	1	1	1	1	3	4	0	1
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	0	0	0	0	0	0	0	0	10	16
Total Current Liabilities	2	2	2	3	3	5	8	9	14	25
Long-Term Debt	0	0	0	0	0	0	1	1	1	1
Deferred Income Tax	0	0	0	0	0	0	0	0	4	3
Minority Interest	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	0	0	0	0	0
Total Liabilities	2 N/A	2 +40%	2 -3%	3 +38%	3 +8%	5 +48%	9 +83%	10 +4%	18 +87%	29 +58%
Equity
Common Stock	134	138	147	148	149	151	152	152	152	152
Retained Earnings	118	128	129	123	110	95	80	54	28	10
Other Equity	0	0	0	0	1	1	0	1	2	3
Total Equity	15 N/A	11 -27%	18 +59%	25 +43%	39 +55%	57 +45%	72 +26%	99 +37%	126 +27%	165 +31%
Total Liabilities & Equity	17 N/A	14 -20%	20 +48%	29 +42%	43 +50%	62 +45%	82 +31%	109 +33%	144 +33%	194 +35%
Shares Outstanding
Common Shares Outstanding	42	45	47	48	48	49	49	49	49	49

Clinuvel Pharmaceuticals Ltd
ASX:CUV